Orthobiologics Market 2019 – 2030 | Industry Size, Share and Analysis-The Revert News
As per Market Industry Reports (MIR) research findings, automated, standardized, scalable, integrated orthobiologics solutions set to open new avenues for stakeholders.
Growth opportunities in the global orthobiologics market looks promising for the next eight to ten years. Increasing number of sports related injuries and road accidents, technological advancements in the regenerative medicine and stem cell therapy arena, rising prevalence of spine related surgeries, and high incidence of musculoskeletal disorders are some of the critical factors driving the global orthobiologics market.
Get FREE Sample Copy with TOC to understand the structure of the complete report @ https://www.marketindustryreports.com/pdf/2
Technological advancements have also played a key role in shaping the growth of the orthobiologics market. For instance, in January, 2019, Medtronic launched a new spinal robot in US. The technology incorporates Medtronic’s Stealth software with Mazor X, a robotic-assisted spine surgery platform that includes image guidance and navigation.
“Companies are focusing on offering innovative solutions in orthopedics that help improving patients and hospital outcomes,” said Anustop, Senior Analyst, Healthcare at MIR.
From a regional perspective, Asia-Pacific is expected to witness highest CAGR in the coming years due to rising focus of major players in emerging Asian countries. Moreover, government support is driving the growth of the orthobiologics market in this region. North America commands the largest share of the orthobiologics market. The large share of this market segment can be attributed to the highly developed healthcare systems and presence of advance therapy for orthopedic treatment. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.
The global orthobiologics market is a structured market and is largely governed by prominent players such as Depuy Synthes, Sanofi, Stryker, Medtronic, Zimmer Biomet Holdings, Inc., Arthrex, Inc., NuVasive, MTF, Bioventus and Seikagaku, among others.
Buy Full Report @ https://www.marketindustryreports.com/checkout/2
By Product Type
- Demineralized Bone Matrix (DBM)
- Bone Morphogenetic Protein
- Stem Cell Therapy
- Spinal Fusion
- Soft-Tissue Injuries
- Reconstructive Surgery
By End User
- Ambulatory Care Centers and Orthopedic Clinics
- Hospitals and Clinics
REASONS TO BUY THE REPORT:
- Deep-rooted quantitative and qualitative insights at segment and sub-segment level
- Global insights with country levels information
- Comprehensive insights on market dynamics, and business environment
- Exhaustive coverage on competitive landscape
- Insights on ‘Key Strategies’ followed by leading players of the market
- Access to ‘Latest Strategic Developments’ registered by leading players of the market
For deep rooted insights on this topic, please visit @ https://www.marketindustryreports.com/orthobiologics-market/2
- Technological Advancement
- Key Distributors List
- Free addition of ‘Company Profiles’
- Clientele Base Assessment
Market Industry Reports is a global leader in market measurement and advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics and hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001,Maharashtra, India
+1 347 767 5477 ( US )
+44 131 463 4161 ( UK )
+ 91 8956 767 535 ( IN )
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Orthobiologics Market 2019 – 2030 | Industry Size, Share and Analysis